K. Misiukiewicz
Papers
1
Total Citations
62
H-Index
1
About
Dr. K. Misiukiewicz is a leading oncologist specializing in head and neck cancers, with a particular focus on human papillomavirus-related oropharyngeal squamous cell carcinoma (HPVOPC). Their most impactful work centers on de-escalation strategies to reduce treatment toxicity while maintaining excellent survival outcomes. As a principal investigator of the landmark Sinai Robotic Surgery (SIRS) Trial (2021, 62 citations), Dr. Misiukiewicz demonstrated that upfront transoral robotic surgery followed by reduced-dose adjuvant therapy can effectively minimize unnecessary side effects for patients with early and intermediate-stage HPVOPC. This paradigm-shifting research addresses the critical challenge of overtreatment in a patient population with historically high survival rates. By integrating minimally invasive surgical techniques with tailored postoperative regimens, their work has directly influenced clinical guidelines and improved quality of life for countless patients. Dr. Misiukiewicz’s contributions exemplify the precision oncology approach, balancing curative intent with functional preservation. Their ongoing investigations continue to refine risk-adapted therapies, cementing their reputation as a pioneer in de-escalation protocols for HPV-driven oropharyngeal cancers.
Research Focus
Key Achievements
Top Papers
- 1